Free Trial

Nicholas Hawkins Sells 6,421 Shares of Arteris (NASDAQ:AIP) Stock

Arteris logo with Computer and Technology background

Key Points

  • Nicholas Hawkins, CFO of Arteris, sold **6,421 shares** of the company at an average price of **$13.21**, totaling **$84,821.41**, resulting in a **6.42% decrease** in his stock ownership.
  • Arteris has a current **market capitalization of $575.35 million**, a **P/E ratio of -16.45**, and an analyst consensus rating of **"Moderate Buy"** with an average target price of **$15.00**.
  • Recent institutional trading saw **Squarepoint Ops LLC** increase its holdings in Arteris by **143.8%**, bringing institutional ownership to **64.36%** of the company.
  • MarketBeat previews the top five stocks to own by November 1st.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) CFO Nicholas Hawkins sold 6,421 shares of the stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $13.21, for a total value of $84,821.41. Following the completion of the transaction, the chief financial officer owned 93,590 shares in the company, valued at $1,236,323.90. The trade was a 6.42% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Arteris Stock Performance

AIP traded up $0.54 during mid-day trading on Wednesday, reaching $13.49. The stock had a trading volume of 816,598 shares, compared to its average volume of 570,721. The stock has a market capitalization of $575.35 million, a P/E ratio of -16.45 and a beta of 1.45. The firm's fifty day simple moving average is $9.78 and its two-hundred day simple moving average is $8.50. Arteris, Inc. has a 52 week low of $5.46 and a 52 week high of $14.58.

Arteris (NASDAQ:AIP - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) EPS for the quarter, meeting analysts' consensus estimates of ($0.11). The firm had revenue of $16.50 million for the quarter, compared to analyst estimates of $16.35 million. Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, analysts expect that Arteris, Inc. will post -0.73 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Weiss Ratings reissued a "sell (d-)" rating on shares of Arteris in a research note on Wednesday. Wall Street Zen raised Arteris from a "sell" rating to a "hold" rating in a research note on Monday, September 15th. Finally, TD Cowen raised their price objective on Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Three research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Arteris currently has a consensus rating of "Moderate Buy" and an average target price of $15.00.

Read Our Latest Research Report on AIP

Institutional Trading of Arteris

Hedge funds and other institutional investors have recently modified their holdings of the company. Squarepoint Ops LLC grew its holdings in shares of Arteris by 143.8% in the 2nd quarter. Squarepoint Ops LLC now owns 120,957 shares of the company's stock valued at $1,153,000 after acquiring an additional 71,340 shares in the last quarter. Marex Group plc acquired a new stake in shares of Arteris in the 2nd quarter valued at approximately $395,000. State of Wyoming bought a new position in shares of Arteris in the second quarter valued at $455,000. Bank of America Corp DE grew its stake in shares of Arteris by 11.8% in the second quarter. Bank of America Corp DE now owns 57,093 shares of the company's stock valued at $544,000 after buying an additional 6,008 shares in the last quarter. Finally, Ameriprise Financial Inc. bought a new stake in Arteris during the second quarter worth $742,000. Institutional investors and hedge funds own 64.36% of the company's stock.

Arteris Company Profile

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Recommended Stories

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Arteris Right Now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.